Company intelligence / Profile preview

Oscare Medical

Vantaa, Finland

Ownership: Private
Development stage: Other

Overview

Oscare Medical is a Finnish healthcare device company focused on bone health assessment and osteoporosis screening. The company developed and commercialized OsCare Sono, a low-frequency ultrasound device used to assess bone strength in the forearm for screening and monitoring purposes. Its technology is designed as a radiation-free, portable alternative for use in clinics and other low-threshold care settings. Founded in 2007, the company was later acquired by Revenio Group and operates as part of that health technology portfolio.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on Oscare Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oscare Medical.

Explore the full profile